Product Description
Product Name |
Quizartinib |
Appearance |
White or off-white crystalline powder |
Latin Name |
AC220 |
CAS NO |
950769-58-1 |
MF |
C29H32N6O4S |
MW |
560.66718 |
Assay |
99% |
Shelf life |
2 years |
Brand |
Sonwu |
Detailed Photos
Function
Quizartinib (AC220) is a second-generation FLT3 inhibitor, acts on Flt3 (ITD/WT), with IC50 of 1.1 nM/4.2 nM in MV4-11 and RS4;11 cells, respectively, acts on Flt3 than on KIT, PDGFRA , PDGFRB, RET, and CSF-1R with 10-fold selectivity.
Company Profile
Recommended products
Capecitabine |
Everolimus |
Afatinib |
Vandetanib |
Gefitinib |
Temozolomid |
Rapamycin |
Axitinib |
Sorafenib tosylate |
Cediranib |
Cabozantinib |
Selumetinib |
Crizotinib |
Sunitinib malate |
Erlotinib |
Crizotinib |
Lapatinib |
Debrafenib |
Cabazitaxel |
Ponatinib |
FAQ
1. Customs clearance
1) By Express:
Normally there is no specical need for the recipient to clear the customs. If the customs has an objection,our rich experienced and peofessional group will help you clear the customs.
2) By Air and by Sea:
Our company will cooperate with the recipient to provide relevant file and information in the customs clearance procedure.
2. Payment
T/T,Western Union,MoneyGram,Trade Assurance Order,L/C etc.